Managing food allergy immunotherapy in children during the COVID-19 pandemic

• Simona Barni ^[1] ; Mattia Giovannini ^[1] ; Lucrezia Sarti ^[1] ; Giulia Liccioli ^[1] ; Benedetta Biagioni ^[1] ; Elio Novembre ^[1] ; Francesca Mori ^[1]
  1. [1] Meyer Children’s Hospital, Florence, Italy.
• Localización: Allergologia et immunopathologia: International journal for clinical and investigate allergology and clinical immunology, ISSN-e 1578-1267, ISSN 0301-0546, Vol. 49, Nº. 1, 2021, págs. 150-152
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Food allergy immunotherapy is a promising allergen-specific approach to manage food allergy in children, although it is not exempt from adverse events, even severe. The adverse events are not predictable and furthermore cofactors can play a role in triggering them. During the COVID-19 pandemic, patients on food allergy immunotherapy should be provided with suggestions on how to proceed in the event of COVID-19 infection occurring or is suspected. These recommendations would be of support to clinical practitioners dealing with patients on food allergy immunotherapy since there is little data in the literature on the topic.